Clin2
NCT03040583Possibly a fitRecruiting

Study of people with primary Sjögren’s syndrome

Primary Sjögren's Syndrome

Part of Immune system & allergy clinical trials.

This study follows adults with primary Sjögren’s syndrome. It may help researchers understand the condition better by using information from people who have already joined the earlier ASSESS study.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
395 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be at least 18 years old.
  • You must have primary Sjögren’s syndrome (not Sjögren’s caused by another disease).
  • You must have already taken part in the earlier ASSESS study.
  • Your Sjögren’s cannot be “secondary,” meaning linked to other autoimmune diseases.
  • If your Sjögren’s is related to another autoimmune condition, you would likely not qualify.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03003572Recruiting
Test an immune marker in primary Sjögren’s disease activity

This study looks at an immune reaction (called anti-Ro/SSA IgE) to see how active primary Sjögren’s disease is. It may help doctors better understand what’s driving symptoms and activity levels over time.

Bourgoin
NCT07727486Not yet recruiting· Phase 2
Study of ICP-488 for Primary Sjögren's Syndrome

This study tests an investigational drug called ICP-488 for people with primary Sjögren's syndrome (the main form, not caused by other conditions). The goal is to see if the drug can help control symptoms better than a placebo. Participants must have active disease and stable treatment.

Beijing, Beijing Municipality
NCT06979531Recruiting· Phase 2
A study of IMVT-1402 for Sjogren's disease with moderate to severe symptoms

This trial tests an experimental drug, IMVT-1402, in adults with primary Sjogren's disease who have moderate to severe symptoms. The goal is to see if it can reduce disease activity safely.

Covina, California
NCT04981145Recruiting· Phase 4
Iguratimod for Sjögren’s syndrome symptoms and safety

This trial studies whether iguratimod improves symptoms in people with primary Sjögren’s syndrome, and checks how safe it is. It focuses on people with confirmed disease markers (anti-SSA/Ro-60) and ongoing dry eyes and dry mouth.

Hangzhou, Zhejiang
NCT04848870Recruiting
Check dental and gum health in Sjögren’s disease

This study looks at dental and gum (periodontal) health in adults with Sjögren’s syndrome. It may help researchers understand how Sjögren’s affects the mouth and how patients can be supported better.

Ivry-sur-Seine, Île-de-France Region
NCT03509064Recruiting
Study of quality of life in Sjögren nerve pain

This trial looks at people with Sjögren who may have small-fiber nerve problems that can cause pain, temperature-related nerve symptoms, or body-function nerve issues. It aims to understand how these nerve problems affect quality of life and medical needs, and compare them with people without neuropathy.

Paris

Hear when a new Primary Sjögren's Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.